新闻
13 小时之前
Evaxion announces plan to implement ADS ratio change
免疫疗法疫苗
13 小时之前
临床2期临床结果
13 小时之前
Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)
申请上市
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy
引进/卖出优先审批
Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
临床结果
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
上市批准
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
临床结果
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
siRNA信使RNA寡核苷酸疫苗
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
临床研究
Scientists report studies showing a novel drug repairs myelin and restores nervous system function in a model of multiple sclerosis